within Pharmacolibrary.Drugs.ATC.J;

model J04AA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.82,
    Cl             = 0.00011666666666666667,
    adminDuration  = 600,
    adminMass      = 4000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013833333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J04AA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Calcium aminosalicylate, also known as calcium para-aminosalicylate, is a salt form of para-aminosalicylic acid (PAS). It is an antibacterial agent historically used as a second-line drug in the treatment of tuberculosis, particularly for strains resistant to first-line agents. Its use has largely declined due to the development of more effective and better-tolerated therapies.</p><h4>Pharmacokinetics</h4><p>Due to the lack of recent published pharmacokinetic (PK) studies specific to calcium aminosalicylate, PK parameters are estimated based on older data for para-aminosalicylic acid and its salts in adult subjects receiving oral doses.</p><h4>References</h4><ol><li><p>Das, KM, &amp; Dubin, R (1976). Clinical pharmacokinetics of sulphasalazine. <i>Clinical pharmacokinetics</i> 1(6) 406–425. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197601060-00002&quot;>10.2165/00003088-197601060-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15752/&quot;>https://pubmed.ncbi.nlm.nih.gov/15752</a></p></li><li><p>Konishi, T (2000). [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine]. <i>Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan</i> 120(1) 1–15. DOI:<a href=&quot;https://doi.org/10.1248/yakushi1947.120.1_1&quot;>10.1248/yakushi1947.120.1_1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10655778/&quot;>https://pubmed.ncbi.nlm.nih.gov/10655778</a></p></li><li><p>Rahman, F, &amp; Cain, GD (1973). Current concepts in therapy: drug-induced malabsorption--a review. <i>Southern medical journal</i> 66(6) 724–727. DOI:<a href=&quot;https://doi.org/10.1097/00007611-197306000-00024&quot;>10.1097/00007611-197306000-00024</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4598189/&quot;>https://pubmed.ncbi.nlm.nih.gov/4598189</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J04AA03;
